If you are a Healthcare Professional and you would like to log in to access this content, please click "Login".
You are now leaving the Lilly Medical Web site
Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
Emgality ® ▼ (galcanezumab)
This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information:
Emgality Summary of Product Characteristics (SmPC)
Emgality® (galcanezumab) Pen: Information on Needle
The pre-filled pen comes with a 27 gauge (thin wall) x 12.7 mm permanently built in needle.
needle is built into the cartridge that is inside the pen and cannot
be changed or taken off. The needle or needle attachment must not be
needle included in the pack is only suitable for subcutaneous
from the Needle
drop of medicine may be seen when the base cap is removed. It is okay
to see a drop of liquid on the tip of the needle.3
This will not affect the dose. 1
Pen Function: Needle Retraction
the medicine is completely delivered, the needle begins to travel
upward (retract). The patient may feel the needle travel upwards in
the pen. The second loud click is heard right before the needle stops
retracting. The whole process of the needle retraction occurs very
the needle does not retract after the injection the needle must
not be touched and the base cap must not be replaced. The pen must be
stored in a safe place to avoid an accidental needlestick injury.
Patients can contact their doctor, pharmacist or nurse for
instructions on how to return the pen.3
instructions for using the pen included with the Package Leaflet,
must be followed carefully. The pre-filled pen is for total use
training, patients may self-inject galcanezumab if a healthcare
professional determines that it is appropriate. 2
Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Emgality [summary of product characteristics]. Eli Lilly Nederland
B.V., The Netherlands.
Emgality [instructions for use]. Eli Lilly Nederland B.V., The
medicinal product is subject to additional monitoring. This will
allow quick identification of new safety information. Healthcare
professionals are asked to report any suspected adverse reactions.
Date of Last Review:February 15, 2019
Are you satisfied with this content?
Call or Email us
If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at firstname.lastname@example.org